Demiditraz is an imidazoline derivative acting as a selective serotonin reuptake inhibitor, primarily indicated for the management of major depressive disorder and obsessive-compulsive disorder. This category… Read more
Demiditraz is an imidazoline derivative acting as a selective serotonin reuptake inhibitor, primarily indicated for the management of major depressive disorder and obsessive-compulsive disorder. This category provides essential reference materials for laboratories engaged in the analytical assessment of this pharmaceutical agent. Included are the active pharmaceutical ingredient, its specific enantiomers, and racemic hydrochloride salts, alongside critical impurities and metabolic derivatives such as N-glucuronide and N-hydroxy compounds. These high-quality reference standards are vital for rigorous impurity profiling, method validation, and ongoing quality control protocols. By utilizing precise, characterized standards and stable isotope-labelled compounds, researchers can ensure accurate identification and quantification during stability testing and pharmacokinetic studies. These materials support the development of robust analytical procedures, ensuring the consistent therapeutic integrity of the drug throughout its lifecycle in clinical and regulatory environments.